BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:39 PM
 | 
Sep 19, 2012
 |  BC Extra  |  Company News

Selexys raises $23M, grants Novartis acquisition option

Selexys Pharmaceuticals Corp. (Oklahoma City, Okla.) raised $23 million in a series A round from new investor MPM Capital and granted Novartis AG (NYSE:NVS; SIX:NOVN) an exclusive option to acquire the company....

Read the full 150 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >